HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.

Abstract
We report two cases of clinically amyopathic dermatomyositis (CADM) complicated by rapid progress interstitial lung disease (RPILD). The diagnosis of CADM was based on Gottron's papule and RPILD, and the absence of muscle weakness. The female patients were treated with early immunosuppressive therapies including steroid pulse therapy, resulting in significant improvement in respiratory symptoms, clinical data, and imaging. Measurement of anti-CADM-140/MDA5 antibody was useful for obtaining a definitive diagnosis of CADM in these cases.
AuthorsYoshiro Horai, Eriko Isomoto, Tomohiro Koga, Akitomo Okada, Shin-Ya Kawashiri, Mami Tamai, Satoshi Yamasaki, Hideki Nakamura, Tomoki Origuchi, Yasuhito Hamaguchi, Manabu Fujimoto, Masataka Kuwana, Atsushi Kawakami
JournalModern rheumatology (Mod Rheumatol) Vol. 23 Issue 1 Pg. 190-4 (Jan 2013) ISSN: 1439-7609 [Electronic] England
PMID22460910 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • CADM-140 peptide, human
  • Glucocorticoids
  • Immunosuppressive Agents
  • Intercellular Signaling Peptides and Proteins
  • Peptides
Topics
  • Adult
  • Autoantibodies (blood)
  • Dermatomyositis (complications, diagnosis, drug therapy)
  • Drug Therapy, Combination
  • Early Diagnosis
  • Female
  • Glucocorticoids (administration & dosage, therapeutic use)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Intercellular Signaling Peptides and Proteins
  • Lung Diseases, Interstitial (complications, diagnosis, drug therapy)
  • Middle Aged
  • Muscle Weakness
  • Peptides (immunology)
  • Prognosis
  • Pulse Therapy, Drug
  • Radiography, Thoracic
  • Recovery of Function
  • Remission Induction
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: